Log In
CQMS
Make a Donation
Log In
Donate
  • Radiation Medicine
  • About Us
    • Our People
      • Our Board
      • Our Staff
      • Scientific Committee
    • Corporate Partners
    • Facility Alliance Members
    • President’s Message
    • Mission and Values
    • Cancer Research Careers
  • Our Research
    • Radiation Therapy Quality Assurance
    • All Trials
    • Open Trials – Recruiting
    • Open Trials – In Follow Up
    • Past Trials
    • Publications
  • Participants & Carers
    • Participant Stories
    • What is a Clinical Trial?
    • Radiation Therapy FAQs
  • Health & Research Professionals
    • Membership
    • New Proposals
    • Events
    • 2025 Annual Scientific Meeting
    • Grants
  • News & Resources
    • News
    • Glossary
    • Helpful Links
    • Reports
  • Support Us
    • Donate or fundraise for TROG
    • Ways to Donate
    • Trek4TROG Light-to-Light Challenge
    • TROG Ambassadors
  • Contact Us
  • Radiation Medicine
  • About Us
    • Our People
      • Our Board
      • Our Staff
      • Scientific Committee
    • Corporate Partners
    • Facility Alliance Members
    • President’s Message
    • Mission and Values
    • Cancer Research Careers
  • Our Research
    • Radiation Therapy Quality Assurance
    • All Trials
    • Open Trials – Recruiting
    • Open Trials – In Follow Up
    • Past Trials
    • Publications
  • Participants & Carers
    • Participant Stories
    • What is a Clinical Trial?
    • Radiation Therapy FAQs
  • Health & Research Professionals
    • Membership
    • New Proposals
    • Events
    • 2025 Annual Scientific Meeting
    • Grants
  • News & Resources
    • News
    • Glossary
    • Helpful Links
    • Reports
  • Support Us
    • Donate or fundraise for TROG
    • Ways to Donate
    • Trek4TROG Light-to-Light Challenge
    • TROG Ambassadors
  • Contact Us
  • Radiation Medicine
  • About Us
    • Our People
      • Our Board
      • Our Staff
      • Scientific Committee
    • Corporate Partners
    • Facility Alliance Members
    • President’s Message
    • Strategic Plan 2020-2023
    • Cancer Research Careers
  • Our Research
    • Radiation Therapy Quality Assurance
    • All Trials
    • Open Trials – Recruiting
    • Open Trials – In Follow Up
    • Upcoming Trials
    • Past Trials
    • Publications
  • Participants & Carers
    • Participant Stories
    • What is a Clinical Trial?
    • Radiation Therapy FAQs
  • Health & Research Professionals
    • Membership
    • New Proposals
    • Events
    • 2025 Annual Scientific Meeting
    • Grants
  • News & Resources
    • News
    • Glossary
    • Helpful Links
    • Reports
  • Support Us
    • Trek4TROG Light-to-Light Challenge
    • Ways to Donate
    • Donate or fundraise for TROG
    • TROG Ambassadors
  • Contact Us
  • Radiation Medicine
  • About Us
    • Our People
      • Our Board
      • Our Staff
      • Scientific Committee
    • Corporate Partners
    • Facility Alliance Members
    • President’s Message
    • Strategic Plan 2020-2023
    • Cancer Research Careers
  • Our Research
    • Radiation Therapy Quality Assurance
    • All Trials
    • Open Trials – Recruiting
    • Open Trials – In Follow Up
    • Upcoming Trials
    • Past Trials
    • Publications
  • Participants & Carers
    • Participant Stories
    • What is a Clinical Trial?
    • Radiation Therapy FAQs
  • Health & Research Professionals
    • Membership
    • New Proposals
    • Events
    • 2025 Annual Scientific Meeting
    • Grants
  • News & Resources
    • News
    • Glossary
    • Helpful Links
    • Reports
  • Support Us
    • Trek4TROG Light-to-Light Challenge
    • Ways to Donate
    • Donate or fundraise for TROG
    • TROG Ambassadors
  • Contact Us

TROG 95.01 – Rectal Cancer

    1. Home
    2. Trial
    3. TROG 95.01 – Rectal Cancer
  • By w.paterson
  • 15 August, 2021
  • 0 Comments
Completed
Gastrointestinal

A Randomised Trial Comparing Adjuvant Protracted Venous Infusion and Bolus 5FU/Leucovorin with Either Early or Late Radiotherapy in Rectal Caner

Primary Sponsor

Trans Tasman Radiation Oncology Group (TROG)
Prev Post

TROG 95.02 – Proctitis – Rectal Sucralfate

Next Post

TROG 94.01/AGITG IG9401 – Oesophagus – Localised Resectable (IG9401)

Related Post

HeSANDA database for clinical trial data
21 April, 2025

Trial data-sharing made easier with HeSANDA initiative

Latest News: 21 April 2025 TROG Cancer Research is

SMART trial grant
16 April, 2025

Mark Hughes Foundation grant for innovative SMART trial into brain metastases

LATEST NEWS: 15 April 2025 An innovative trial aimed

Recent Posts

  • Trial data-sharing made easier with HeSANDA initiative
  • Mark Hughes Foundation grant for innovative SMART trial into brain metastases
  • TROG ASM fosters collaboration between consumers and researchers
  • How TROG enhanced my career: Professor Bryan Burmeister reflects on three decades of research
  • TROG Awards Recognise Research Excellence

Categories

  • Events 8
  • General 18
  • Journal 1
  • Participant Stories 12
  • Prostate Cancer 1
  • RAVES Trial 1
  • Trials 13
Register now

For over 30 years, Trans-Tasman Radiation Oncology Group has been dedicated to improving the way radiation medicine is delivered to cancer patients with ongoing scientific research, clinical trials, and cutting-edge technology.

Facebook-f X-twitter Youtube Instagram

Quick Links

  • About Us
  • Our Research
  • Participants & Carers
  • Health & Research Professionals
  • News & Resources
  • Support Us
  • Contact Us

Legalities

  • Privacy Policy
  • Complaints & Feedback
  • Copyright Statement
  • Terms & Conditions
  • Cookie Warning
  • TROG Constitution

Latest News

Keep up to date with TROG news, subscribe to our community newsletter.

Subscribe

ABN:  45 132 672 292

TROG Cancer Research © 2025. All rights reserved

Website developed by the Marketing GP